Clinical Pharmacology Intern (Graduate-Level) jobs in United States
cer-icon
Apply on Employer Site
company-logo

Alexion Pharmaceuticals, Inc. · 21 hours ago

Clinical Pharmacology Intern (Graduate-Level)

Alexion Pharmaceuticals, Inc. is seeking Master's and PhD students for a 10-week internship role focused on clinical pharmacology and PKPD modeling. The intern will support exploratory analyses and assist with data analysis or modeling related to dosing schedule optimization for T cell engagers.

BiotechnologyHealth CareMedicalTherapeutics
check
Comp. & Benefits
badNo H1Bnote

Responsibilities

Support exploratory PK/PD and translational analyses to evaluate dosing schedule optimization for T cell engagers
Review relevant literature, assist with data analysis or modeling, and help generate hypotheses on when less frequent dosing may preserve efficacy and reduce toxicity

Qualification

PKPD modelingClinical pharmacologyData analysisRPythonMathematicsStatisticsPublic speakingPresentation design

Required

Master's and PhD students studying PKPD modeling, Clinical pharmacology, Pharmaceutical Science, Mathematics, Statistics, or a related discipline
Candidates must have an expected graduation date after August 2026
Knowledge of PK/PD and clinical pharmacology are required
US Work Authorization is required at time of application
Ability to report onsite to Waltham, MA site 3-5 days per week

Preferred

Experience with data analysis/modeling tools such as R or Python
Experience with clinical study
Enthusiasm for collaboration, cross-functional projects, public speaking, and presentation design

Benefits

Short-term incentive bonus opportunity
Equity-based long-term incentive program (salaried roles)
Retirement contribution (hourly roles)
Commission payment eligibility (sales roles)
Qualified retirement program [401(k) plan]
Paid vacation and holidays
Paid leaves
Health benefits including medical, prescription drug, dental, and vision coverage

Company

Alexion Pharmaceuticals, Inc.

company-logo
Alexion, AstraZeneca Rare Disease is focused on pioneering new possibilities for the rare disease community.

Funding

Current Stage
Public Company
Total Funding
$5.8M
2020-12-12Acquired
1999-02-12Post Ipo Equity· $5.8M
1996-02-29IPO

Leadership Team

leader-logo
Frederic Chereau
SVP, Strategy and Business Development
linkedin
leader-logo
Imran Shakur
Director, IRT and Technology Lead
linkedin
Company data provided by crunchbase